Intracranial Aneurysms Market Strengthens as Endovascular Therapies Become Global Standard of Care

Market Definition
The intracranial aneurysms market includes all devices and technologies used for diagnosing and treating aneurysmal dilatations in the cerebral arteries. This primarily covers:
• Endovascular devices
o Detachable coils (bare, hydrogel-coated, complex-shaped)
o Flow-diverter stents
o Intrasaccular devices and neck-bridging implants
o Liquid embolics
o Microcatheters, guide catheters, and balloon-remodeling systems
• Neurosurgical products
o Aneurysm clips and cranial fixation accessories
The market is driven by treatment of both ruptured aneurysms (subarachnoid hemorrhage) and the increasing number of incidentally discovered unruptured aneurysms.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72112

Market Size, CAGR & Forecast
After consolidating major global studies, the consensus positioning is:
• 2024-2025 market size: USD 1.5-1.7 billion
• 2032-2035 forecast: USD 2.6-3.6 billion
• Expected CAGR: ~8-9%
The fastest growth comes from endovascular segments-especially flow-diversion and intrasaccular devices-while traditional coiling remains the highest-volume procedure.

Key Growth Drivers
1. Increasing Detection of Aneurysms
Greater use of CT and MR angiography for headaches, trauma, and stroke evaluation is leading to more incidental aneurysm diagnosis, expanding the elective treatment pool.
2. Shift Toward Minimally Invasive Endovascular Therapy
Endovascular treatment is now preferred in most high-income regions due to lower morbidity, shorter hospital stays, and improved device safety. This directly increases demand for coils, flow-diverters, and microcatheters.
3. Expansion of Stroke & Aneurysm Centers
Growth of comprehensive stroke centers, especially in North America, Europe, China, India, and the Middle East, is boosting procedural volumes and accelerating technology adoption.
4. Rapid Device Innovation
Next-generation flow-diverters, low-profile stents, enhanced coil designs, and intrasaccular implants enable treatment of complex, wide-necked, and bifurcation aneurysms that were previously difficult or impossible to manage endovascularly.
5. Growing Elective Treatment of Unruptured Aneurysms
Clinical evidence supporting early treatment in selected patients is pushing demand for durable, low-risk device solutions.

Market Segmentation
By Treatment Modality
Endovascular Coiling (largest segment)
• Backbone of ruptured and unruptured aneurysm treatment.
• Includes bare platinum coils, hydrocoils, 2D/3D coils, and adjunctive balloon or stent assistance.
Flow-Diverter Stents (fastest-growing segment)
• Preferred for large, wide-necked, and complex aneurysms.
• Strong double-digit growth in many markets.
Intrasaccular & Neck-Bridging Devices
• Increasingly used for bifurcation aneurysms.
• Significant adoption in high-volume neurointerventional centers.
Surgical Clipping
• Still essential for selected morphologies, younger patients, and resource-limited settings.
• Represents a smaller share in developed regions.

By Aneurysm Type
• Ruptured aneurysms (SAH) - high-acuity, emergency cases requiring immediate endovascular or surgical intervention.
• Unruptured aneurysms - increasingly treated electively before rupture risk escalates.

By End User
• Comprehensive stroke centers
• Tertiary and academic hospitals
• High-volume neurointerventional centers
• Regional hospitals upgrading towards endovascular capabilities

Explore Full Report here: https://exactitudeconsultancy.com/reports/72112/intracranial-aneurysms-market

Regional Insights
North America
Largest share globally; high imaging utilization, mature stroke networks, robust reimbursement, and top-tier device innovation drive strong market performance.
Europe
Highly developed neurointerventional infrastructure; widespread adoption of advanced coils and flow-diverters. Western Europe remains the technology leader.
Asia-Pacific (fastest-growing region)
Rapid expansion of neurointerventional programs in China, Japan, India, and South Korea. High incidence of aneurysms combined with growing healthcare investment fuels device demand.
Latin America & Middle East/Africa
Growing but uneven adoption. Major cities are investing in advanced angiography suites and neurointervention training, creating long-term opportunity.

Competitive Landscape - Key Players
Typical leaders in the intracranial aneurysm device segment include:
• Medtronic
• Stryker Neurovascular
• Johnson & Johnson (Cerenovus)
• Penumbra
• Terumo / MicroVention
• Balt
• Phenox (Wallaby Medical)
• Asahi Intecc
• Acandis
• Kaneka
• Rapid Medical
• Emerging manufacturers in China, India, Europe

Conclusion
The Intracranial Aneurysms Market is one of the fastest-advancing segments of neurovascular intervention. With:
• A 2024-2025 size of USD 1.5-1.7 billion,
• A 2032-2035 outlook of USD 2.6-3.6 billion, and
• An 8-9% CAGR,
the market is being propelled by rapid endovascular adoption, greater aneurysm detection, continuous device innovation, and expansion of neurointerventional centers worldwide.

This report is also available in the following languages : Japanese (頭蓋内動脈瘤市場), Korean (두개내 동맥류 시장), Chinese (颅内动脉瘤市场), French (Marché des anévrismes intracrâniens), German (Markt für intrakranielle Aneurysmen), and Italian (Mercato degli aneurismi intracranici), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/72112

Our More Reports:

Intracranial Pressure Monitoring Devices Market
https://exactitudeconsultancy.com/reports/72113/intracranial-pressure-monitoring-devices-market

Intracranial Stents Market
https://exactitudeconsultancy.com/reports/72114/intracranial-stents-market

Neurovascular Accessory Devices Market
https://exactitudeconsultancy.com/reports/72437/neurovascular-accessory-devices-market

Intracranial Hemorrhage Clinical Market
https://exactitudeconsultancy.com/reports/73653/intracranial-hemorrhage-clinical-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.